Russell joined Fideres in 2014. He is member of the management team and is responsible for clients in the UK, Europe and Australia. His current role at Fideres is focused on business development. In the past, Russell has acted as a consulting expert in many large legal cases in the US and UK for a variety of industries. In particular, he leads the pharmaceutical antitrust team in relation to generic drug price-fixing allegations, labour economics team in relation to wage suppression and has carried out expert work in financial markets claims involving swap mis-selling and fund management excess fees. Russell has completed his MBA at Imperial College Business School and his BSc in Accounting and Finance at the London School of Economics and Political Science. He is a Chartered Financial Analyst (CFA) charter holder.
J Wisbey & Associates Pty Ltd v UBS AG, VID 567 of 2019
Pork Antitrust Litigation, 0:18-cv-1776
Generic Pharmaceuticals Pricing Antitrust Litigation (Digoxin), 2:16-md-02724
Alaska Electrical Pension Fund v. Bank Of America Corporation, 1:14-cv-07126-JMF
Treasury Securities Auction Antitrust Litigation, 1:15-md-02673
The Standard Bank of South Africa Limited v. The Competition Commission Of South Africa, CR212Feb17
The Federal Deposit Insurance Corporation v. Barclays Bank Plc & Ors, FL-2017-000002
Hays v. American Century Capital Portfolios, Inc., 3:21-cv-08625-CRB
Ontario Teachers’ Pension Plan Board v. Teva Pharmaceutical Industries Ltd., 3:17-cv-00558
Aug 2014 – to date
Fideres Partners LLP, Director
2019 – 2022, Imperial College Business School, MBA Strategy
2015 – 2018, CFA Institute, Chartered Financial Analyst (CFA) Charterholder
2011 – 2014, London School of Economics and Political Science, BSc Accounting and Finance
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611